SINCE late last year, drug companies have been told to reformulate their drugs containing phenylpropanolamine following an adverse finding on this ingredient in its effect to patients especially women and possibly children.

A study by drug authorities in the United States has linked phenypropanolamine to increased cases of hemorrhagic strokes (bleeding in the brain) among women ages 18-49 within three days after first use of medication that has this active ingredient.

Problems though were not found in men by the Food and Drugs Administration has recommended that everyone, including children “seek alternative medicine” in the wake of the medical findings. 

A patient, Marissa Espiritu, in a multi-forwarded e-mail has sounded the alarm after she herself had called up the number 800-548-3708 written in a box of Triaminic and was told the Read more